NCCN Guidelines for Patients® Myeloproliferative Neoplasms (MPN)


Book Description

[OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network (NCCN) comes this essential guide to Myeloproliferative Neoplasms (MPN). Based on clinical treatment guidelines used by doctors and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include: MPN basics, Know your MPN, Symptoms and surveys, Clotting complications, Myelofibrosis, Supportive care for symptoms, Making treatment decisions, Words to know, NCCN Contributors, NCCN Cancer Centers, Index. Let this authoritative handbook be your guide!




NCCN Guidelines for Patients® Myeloproliferative Neoplasms


Book Description

[OFFICIAL CURRENT VERSION - 2019] From the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to Myeloproliferative Neoplasms. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients help prepare patients and caregivers to talk with their doctors and make treatment decisions. Topics include: MPN basics, tests for MPN; treatment for polycythemia vera, essential thrombocythemia, myelofibrosis; and making treatment decisions. Let this authoritative handbook be your guide!




NCCN Guidelines for Patients®


Book Description

From the medical leaders of 27 leading cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to myeloproliferative neoplasms (MPN). Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide!Part 1 ¿ MPN basics: Explains the classic types of MPN.Part 2 ¿ Treatment planning: Testing for MPN: Describes the tests used to confirm MPN and plan treatment.Part 3 ¿ Treatment guide - Essential thrombocythemia: Presents treatment options for ET with no myelofibrosis present.Part 4 ¿ Treatment guide - Polycythemia vera: Presents treatment options for PV with no myelofibrosis present.Part 5 ¿ Treatment guide - Myelofibrosis: Presents treatment options for primary myelofibrosis and ET and PV that have transformed to myelofibrosis.Part 6 ¿ Making treatment decisions: Offers tips for choosing the best treatment.A complete glossary with dictionary and acronyms completes this book.




NCCN Guidelines for Patients®


Book Description

From the medical leaders of 27 leading cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to myeloproliferative neoplasms (MPN). Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide!Part 1 ¿ MPN basics: Explains the classic types of MPN.Part 2 ¿ Treatment planning: Testing for MPN: Describes the tests used to confirm MPN and plan treatment.Part 3 ¿ Treatment guide - Essential thrombocythemia: Presents treatment options for ET with no myelofibrosis present.Part 4 ¿ Treatment guide - Polycythemia vera: Presents treatment options for PV with no myelofibrosis present.Part 5 ¿ Treatment guide - Myelofibrosis: Presents treatment options for primary myelofibrosis and ET and PV that have transformed to myelofibrosis.Part 6 ¿ Making treatment decisions: Offers tips for choosing the best treatment.A complete glossary with dictionary and acronyms completes this book.




Myeloproliferative Neoplasms


Book Description

This book focuses on three of the main categories of myeloproliferative neoplasm: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Relevant laboratory and clinical advances are comprehensively covered, and great emphasis is placed on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic approaches, the value and limitations of mutation screening for diagnostic and prognostic purposes, risk stratification in terms of both survival and other disease complications such as leukemic transformation and thrombosis, and modern therapeutic strategies, including conventional drugs, allogeneic stem cell transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field.




Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A


Book Description

Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A, Volume 365 in the International Review of Cell and Molecular Biology series reviews and details current advances in cell and molecular biology. Chapters in this new release include MPN a continuum of different disease entities, Bone marrow microenvironment of MPN, Extramedullary hemopoiesis in MPN, The JAK2 mutation, Calreticulin mutations in myeloproliferative neoplasms, and Cytogenetic abnormalities and non-driver mutations in MPN. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists. The articles published in IRCMB have a high impact and an average cited half-life of 9 years. This great resource ranks high amongst scientific journals dealing with cell biology. Publishes only invited review articles on selected topics Authored by established and active cell and molecular biologists and drawn from international sources Offers a wide range of perspectives on specific subjects




Fast Facts: Myeloproliferative Neoplasms


Book Description

Presentation of the myeloproliferative neoplasms (MPNs) varies widely, and correct diagnosis and management can be challenging, and is becoming more complex as understanding of the underlying molecular basis for these disorders emerges. Appropriate management is increasingly informed by accurate risk stratification founded on understanding of cytogenetic and molecular markers, as well as the clinical presentation. 'Fast Facts: myeloproliferative neoplasms' focuses on the three most common chronic MPNs: • Essential thrombocythemia (ET) – characterized by increased platelet count • Polycythemia vera (PV) – characterized by excessive production of red blood cells • Primary myelofibrosis – a more severe and heterogenous disorder that may overlap with ET and PV but is commonly associated with anemia. Written by two leading experts in the field, Fast Facts: myeloproliferative neoplasms provides concise, up-to-date and practical guidance on the accurate diagnosis, risk stratification and management of these MPNs. It also provides key insights into our growing understanding of the underlying molecular and genetic basis of these disorders, and how this is informing risk stratification and management strategies. This concise handbook will be invaluable to clinicians, medical students, nurses, pharmacists and scientists in understanding and overcoming the everyday and rarer challenges associated with MPN.




Oxford Specialist Handbook: Myeloproliferative Neoplasms


Book Description

Our understanding of myeloproliferative neoplasms (MPN) disorders, a group of clonal haematological malignancies characterized by excessive accumulation of one or more myeloid cell lineages, has grown considerably over the past four decades. Myeloproliferative Neoplasms offers a detailed evidence-based guide to MPNs in an easily accessible format, structured to facilitate learning specialist information by presenting core information in 'bite size' chunks. Each chapter summarises the state-of-the art preclinical and clinical knowledge, and its impact on the clinical management of patients with MPNs. This practical guide, written by experts in the field, is essential reading for oncologists, haematologists, and other health care professionals interested in the field of MPNs.




Chronic Myeloproliferative Disorders


Book Description

With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients. This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.




The MD Anderson Manual of Medical Oncology, Fourth Edition


Book Description

Expert, hands-on guidance for the practicing oncologist—from the leader in the field of cancer management—completely updated to reflect the latest advances A Doody's Core Title for 2023! Comprehensive and authoritative, The MD Anderson Manual of Medical Oncology delivers everything you need to accurately diagnose and effectively treat a wide range of cancers—including leukemia, lymphoma, myeloma, lung and breast cancer, genitourinary carcinoma, melanoma, and sarcoma. This unmatched resource emphasizes practical, actionable steps to cancer treatment, providing "to the point" recommendations, chapter summary boxes, tables, charts, expert opinion and patient education boxes, practice tips, cases, and prescriptive advice. The new format of this updated edition quickly guides you to the topic, the affiliated relevant chapter, new findings affecting clinical practice, and reference/evidence. This fourth edition features: NEW Q&A, cases, patient education information, and expert advice Expanded coverage of immunotherapy treatment—written by the 2018 Nobel Prize-winner for immunology Access to continually updated online content A comparative table with guidelines from the European Society of Medical Oncology and the American Society of Clinical Oncology An emphasis on recent developments in precision medicine and immunotherapies Plus important NEW chapters on: Cord blood transplant Haploidentical cell transplantation Cellular therapy in allogeneic hematopoietic cell transplantation Pediatric cancers Molecular biomarkers and cancer Immune-oncology Targeted therapies in cancer Applied biostatistics Oncocardiology Pulmonary complications of cancer associated thrombosis